Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1972 Nov;27(6):643–653. doi: 10.1136/thx.27.6.643

Neuraminic acid content of sputum in chronic bronchitis

E E Keal 1,2, Lynne Reid 1,2
PMCID: PMC469962  PMID: 4647626

Abstract

The neuraminic acid content of sputum from 48 men with early chronic bronchitis has been estimated in samples collected over a period of three years. The results are compared with those from 29 advanced bronchitic patients and are related to the clinical features of both groups and to the physical and biological properties of the sputum. A seasonal variation in neuraminic acid content has been noted for the first time with higher levels during the winter months. Clinical assessment of sputum pourability correlated well with measured viscosity. The viscosity of mucoid sputum was related to its neuraminic acid content but also to the yield of dry macromolecular material. In the early bronchitic group whose sputum was assessed for purulence at monthly intervals pus was more often present in those men whose mucoid sputum contained higher levels of neuraminic acid. These findings are discussed in relation to the cause of exacerbations of chronic bronchitis.

Full text

PDF
645

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUERGI H. ERSTE KLINISCH-EXPERIMENTELLE ERFAHRUNGEN MIT DEM MUCOLYTICUM BISOLVON. Schweiz Med Wochenschr. 1965 Feb 20;95:274–279. [PubMed] [Google Scholar]
  2. Fisher M., Akhtar A. J., Calder M. A., Moffat M. A., Stewart S. M., Zealley H., Crofton J. W. Pilot study of factors associated with exacerbations in chronic bronchitis. Br Med J. 1969 Oct 25;4(5677):187–192. doi: 10.1136/bmj.4.5677.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. GIBBONS R. A. Chemical properties of two mucoids from bovine cervical mucin. Biochem J. 1959 Oct;73:209–217. doi: 10.1042/bj0730209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GIBBONS R. A., GLOVER F. A. The physicochemical properties of two mucoids from bovine cervical mucin. Biochem J. 1959 Oct;73:217–225. doi: 10.1042/bj0730217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gent M., Knowlson P. A., Rime F. J. Effect of bromhexine on ventilatory capacity in patients with a variety of chest diseases. Lancet. 1969 Nov 22;2(7630):1094–1096. doi: 10.1016/s0140-6736(69)90702-8. [DOI] [PubMed] [Google Scholar]
  6. Hamilton W. F., Palmer K. N., Gent M. Expectorant action of bromhexine in chronic obstructive bronchitis. Br Med J. 1970 Aug 1;3(5717):260–261. doi: 10.1136/bmj.3.5717.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jenne J. W., MacDonald F. M., Lapinski E. M., Bratberg N. E., Hall W. H. The course of chronic hemophilus bronchitis treated with massive doses of penicillin and penicillin combined with streptomycin. Am Rev Respir Dis. 1970 Jun;101(6):907–922. doi: 10.1164/arrd.1970.101.6.907. [DOI] [PubMed] [Google Scholar]
  8. Keal E. Méthodes d'étude des modifications de la sécrétion bronchique et de sa viscosité. Poumon Coeur. 1970;26(1):51–58. [PubMed] [Google Scholar]
  9. Langlands J. H. Double-blind clinical trial of bromhexine as a mucolytic drug in chronic bronchitis. Lancet. 1970 Feb 28;1(7644):448–450. doi: 10.1016/s0140-6736(70)90835-4. [DOI] [PubMed] [Google Scholar]
  10. Lawther P. J., Emerson T. R., O'Grady F. W. Haemophilus influenzae: growth stimulation by atmospheric pollutants. Br J Dis Chest. 1969 Jan;63(1):45–47. doi: 10.1016/s0007-0971(69)80043-4. [DOI] [PubMed] [Google Scholar]
  11. MARMION B. P., CURTAIN C. C., PYE J. The effect of human bronchial secretions (sputum) on the haemagglutinin and infectivity of influenza virus. Aust J Exp Biol Med Sci. 1953 Oct;31(5):505–518. doi: 10.1038/icb.1953.54. [DOI] [PubMed] [Google Scholar]
  12. MAY J. R. The bacteriology of chronic bronchitis. Lancet. 1953 Sep 12;265(6785):534–537. doi: 10.1016/s0140-6736(53)90274-8. [DOI] [PubMed] [Google Scholar]
  13. Munies R., Grubb T. C., Caliari R. E. Relationship between sputum viscosity and total sialic acid content. J Pharm Sci. 1968 May;57(5):824–827. doi: 10.1002/jps.2600570522. [DOI] [PubMed] [Google Scholar]
  14. Olitzki L. MUCIN AS A RESISTANCE-LOWERING SUBSTANCE. Bacteriol Rev. 1948 Jun;12(2):149–172. doi: 10.1128/br.12.2.149-172.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SIMON G. RADIOLOGY AND EMPHYSEMA. Clin Radiol. 1964 Oct;15:293–306. doi: 10.1016/s0009-9260(64)80001-5. [DOI] [PubMed] [Google Scholar]
  16. SMITH H. Factors involved in the virulence-enhancing action of mucin. Proc R Soc Med. 1953 Sep;46(9):787–790. [PubMed] [Google Scholar]
  17. Stuart-Harris C. Infection, the environment and chronic bronchitis. J R Coll Physicians Lond. 1971 Jul;5(4):351–361. [PMC free article] [PubMed] [Google Scholar]
  18. WARREN L. The thiobarbituric acid assay of sialic acids. J Biol Chem. 1959 Aug;234(8):1971–1975. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES